No Detail Found!

Surgical outcome after neo-adjuvant chemotherapy in advanced epithelial carcinoma of the ovary

Author(s)
Asma Hameed Saidu Group of Teaching Hospitals (SGTH),Saidu Sharif, Swat,Pakistan
SaniaTanveer Khattak Saidu Group of Teaching Hospitals (SGTH),Saidu Sharif, Swat,Pakistan
Shoukat Ali Swat Institute of Nuclear Medicine, Oncology and Radiotherapy (SINOR) cancer hospital,Saidu Sharif, Swat, KPK,Pakistan
Basir Muhammad Swat Institute of Nuclear Medicine, Oncology and Radiotherapy (SINOR) cancer hospital,Saidu Sharif, Swat, KPK,Pakistan
Ghufran Biradar Swat Institute of Nuclear Medicine, Oncology and Radiotherapy (SINOR) cancer hospital,Saidu Sharif, Swat, KPK,Pakistan
Javaid Ali Larkana Institute of Nuclear Medicine and Radiotherapy (LINAR) cancer hospital,Larkana, Sindh,Pakistan
Shoab Shah Swat Institute of Nuclear Medicine, Oncology and Radiotherapy (SINOR) cancer hospital,Saidu Sharif, Swat, KPK,Pakistan
Hajira Khalid DOW University of Health and Sciences,Karachi,Pakistan
Tabassum Naheed Swat Medical College,Swat, KPK,Pakistan
Abstract
The objective of this prospective study was to find out the surgical outcome/optimal cytoreduction after neoadjuvant chemotherapy (NACT) in advanced epithelial carcinoma of the ovary (EOC). This study of EOC patients with stage III and stage IV (advanced stage) disease was carried out at Swat Institute of Nuclear Medicine, Oncology & Radiotherapy (SINOR) and Swat and Saidu Group of Teaching Hospitals (SGTH), Swat, Pakistan, from January 2017 to January 2021. A total of fifty patients were treated with NACT followed by surgical cytoreduction. SPSS software was used to analyze optimal cytoreduction and overall radiological response rate to NACT. The average age of the patients was 49.04±10.66 years. In marital status, 94% patients were married and family history of ovarian cancer was found positive in 10% patients. 56% patients were with stage III and 44% were with stage IV disease. After NACT radiological complete response (CR), partial response (PR), stable disease (SD) and progressive disease (PD) was observed in 16%, 58%, 20% and 6% patients respectively. Optimal surgical cytoreduction was achieved in 70% patients. NACT in advanced epithelial carcinoma of the ovary showed good promising surgical results. NACT improved patient's quality of life by minimizing more invasive surgical procedure.
Publication Details
Page(s) 629-635
DOI DOI not available
Published Journal: International Journal of Biology and Biotechnology, Volume: 20, Issue: 4, Year: 2023

Request the full text from PASTIC

Keywords
Neoadjuvant chemotherapy, optimal cytoreduction, epithelial ovarian, primary debulking surgery
0

Citations

0

Downloads

61

Views